Meta Pixel

News and Announcements

Ezypay and Instarent Announces New Partnership Aimed to Streamline Payments in the Real Estate Sector

  • Published March 02, 2020 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Newly established partnership between Instarent and Ezypay allows for a seamless payment experience for Instarent’s landlord and tenant users, offering flexible automated billing and one-off tenant payments within the Instarent application. By integrating with Ezypay’s powerful subscription payments platform, Instarent has developed a solution where landlords can manage and track rental payments in real time. This integration is now live and processing payments within the Instarent platform. 

CEO of Ezypay, James Foster, is pleased to partner with Instarent and looks forward to driving progress in the Real Estate industry. “Rental payments in Australia have been stuck in the 1960’s, with tenants and landlords impacted by a lack of choice, slowness of money movement and overall complexity and frustration” explains Foster. “We are excited to partner with Instarent and are confident that our next-generation subscription payments platform can help power their transformation of the rental housing market.”

 

About Instarent

Instarent’s mission is to empower landlords and tenants to self- manage property. They do this with the reinvention of the current process, moving to a paperless platform and rental property management system, built exclusively for landlords and tenants. Instarent’s objective is to even out the field and bring Australia’s first long-term property management application to all the users looking for transparency, reliability and ease of use.

Affordable property management is now within reach. They have brought together property advertising, tenancy applications and property management services into one easy application, removing the need for an agent. End-to-end property management, all in one easy to use app.

Register Interest

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now